Colombia Medica最新文献

筛选
英文 中文
Edición de genes para el tratamiento del cáncer de pulmón (CRISPR-Cas9). 肺癌治疗的基因编辑(CRISPR-Cas9)。
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-12-29 DOI: 10.25100/CM.V47I4.2856
A. Castillo
{"title":"Edición de genes para el tratamiento del cáncer de pulmón (CRISPR-Cas9).","authors":"A. Castillo","doi":"10.25100/CM.V47I4.2856","DOIUrl":"https://doi.org/10.25100/CM.V47I4.2856","url":null,"abstract":"In 2015, the journal Science chose CRISPR-Cas9 technology as the most important technological advance of science in the last years1. This magazine announced the beginning of a new era of biotechnology in which it would be possible to edit, correct and modify the genetic information of any cell in a feasible, fast and cheap way; and most importantly, with high precision. Its implementation in research laboratories in basic and applied sciences could help to develop therapeutic strategies for the health area with the main objective of healing diseases with a known genetic origin, and that until now have been impossible to cure.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"54 1","pages":"178-180"},"PeriodicalIF":1.1,"publicationDate":"2016-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75276173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Polimorfismos en el gen lipoproteína lipasa como marcadores genéticos para enfermedad cerebrovascular en la población colombiana: estudio de casos y controles 作为哥伦比亚人群脑血管疾病遗传标记的脂蛋白脂肪酶基因多态性:病例和对照研究
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-12-21 DOI: 10.25100/CM.V47I4.1683
Leydi Carolina Velásquez Pereira, Clara Inés Vargas Castellanos, F. A. S. Sieger
{"title":"Polimorfismos en el gen lipoproteína lipasa como marcadores genéticos para enfermedad cerebrovascular en la población colombiana: estudio de casos y controles","authors":"Leydi Carolina Velásquez Pereira, Clara Inés Vargas Castellanos, F. A. S. Sieger","doi":"10.25100/CM.V47I4.1683","DOIUrl":"https://doi.org/10.25100/CM.V47I4.1683","url":null,"abstract":"Objective:To analyze if there is an association between the presence of polymorphisms in the LPL gene (rs320, rs285 and rs328) with development of acute ischemic stroke in Colombian population.Methods:In a case control design, 133 acute ischemic stroke patients (clinical diagnosis and x-ray CT) and 269 subjects without stroke as controls were studied. PCR -RFLP technique was used to detect rs320, rs285 and rs328 polymorphisms in the LPL gene.Results:In the present research was not found any association between any of the LPL gene polymorphism and acute ischemic stroke in the population studied; the allele and genotypic frequencies of the studied polymorphisms were similar in cases and controls and followed the Hardy-Weinberg equilibrium. The study was approved by the IRB and each subject signed the informed consent.Conclusion:LPL gene polymorphisms are not genetic markers for the development of stroke in the Colombian sample used.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"16 1","pages":"189-195"},"PeriodicalIF":1.1,"publicationDate":"2016-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74665872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5. 维生素D(25(OH)D)在2-5期慢性肾脏疾病患者中的应用。
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-09-30
César Augusto Restrepo Valencia, José Vicente Aguirre Arango
{"title":"Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.","authors":"César Augusto Restrepo Valencia, José Vicente Aguirre Arango","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To establish the impact the chronic kidney disease stage has in the native vitamin D levels in patients not undergoing dialysis treatment.</p><p><strong>Methods: </strong>A study performed in Manizales, Colombia, a city located 2,200 meters above sea level, without important stational variations. Patients with 18 years of age or more, with chronic kidney disease stages 2 to 5 and not undergoing dialysis treatment were recruited for this study. Demographic and anthropometric variations were evaluated as well as solar exposure, CKD etiology and laboratory variables related to bone and mineral diseases. For each CKD clinical stage, correlations were evaluated for vitamin D levels, laboratory results for bone and mineral diseases, solar exposure and ethnicity.</p><p><strong>Results: </strong>Three hundred thirty-three patients were evaluated with a median age of 71 years, most of them mestizo (71%), 173 were women. The main CKD etiology was hypertensive nephropathy (32.2%). 21.1% of patients had normal vitamin D levels, 70.1% were within insufficient range and 8.8% were in deficit. A negative correlation was found between the levels of vitamin 25 (OH) D and the values for: creatinine, phosphorous, calcium x phosphorous product, PTH, 24 hours urine protein and BMI. A positive relationship was found for calcium and albumin. Positive significant statistical correlation was found for vitamin 25(OH) D levels and solar exposure for stages 3b and 4 of CKD.</p><p><strong>Conclusions: </strong>It is common to find low levels of vitamin 25(OH) D in patients with CKD; these can contribute to the appearance of secondary hyperparathyroidism.</p><p><strong>Objetivo: </strong>Establecer el impacto del estadio clínico en los niveles de vitamina D nativa en pacientes con enfermedad renal crónica (ERC) sin diálisis.</p><p><strong>Métodos: </strong>Estudio realizado en Manizales, Colombia, una ciudad tropical ubicada a 2,200 metros de altura sobre el nivel del mar, sin variaciones estacionales importantes a lo largo del año. Se incluyeron pacientes mayores de 18 años, con enfermedad renal crónica estadio 2 a 5 sin tratamiento dialítico. En ellos se evaluaron variables demográficas, antropométricas, grado de exposición solar, etiología de la enfermedad, y variables de laboratorio relacionadas con desórdenes óseos y minerales. Para cada estadío clínico se evaluó la correlación entre los niveles de vitamina D y los resultados de las pruebas de laboratorio relacionadas con desordenes óseos y minerales, exposición solar y etnia.</p><p><strong>Resultados: </strong>Se evaluaron 331 pacientes, con una edad media de 71 años, la mayoría mestizos (71%), 173 mujeres. La principal etiología de ERC fue nefropatía hipertensiva (33.2%). El 21.1% de los pacientes tenían niveles normales de vitamina D, fueron insuficientes en 70.1% y 8.8% en déficit. Se detectó correlación negativa, entre los niveles de vitamina 25(OH)D y los valores de creatinina, fósforo","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"47 3","pages":"160-166"},"PeriodicalIF":1.1,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72211759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guía de práctica clínica para la prevención, diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años 预防、诊断、治疗和监测18岁以上人群2型糖尿病的临床实践指南
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-06-24 DOI: 10.25100/CM.V47I2.2207
P. Aschner, Oscar Mauricio Muñoz, D. Girón, Olga Milena García, D. F. Fernández Ávila, Luz Ángela Casas, Luisa Fernanda Bohorquez, Clara María Arángo T., L. Carvajal, Doris Amanda Ramírez, J. G. Sarmiento, Cristian Alejandro Colón, Nestor Fabián Correa G., Pilar Alarcón R., Alvaro Andrés Bústamante S.
{"title":"Guía de práctica clínica para la prevención, diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años","authors":"P. Aschner, Oscar Mauricio Muñoz, D. Girón, Olga Milena García, D. F. Fernández Ávila, Luz Ángela Casas, Luisa Fernanda Bohorquez, Clara María Arángo T., L. Carvajal, Doris Amanda Ramírez, J. G. Sarmiento, Cristian Alejandro Colón, Nestor Fabián Correa G., Pilar Alarcón R., Alvaro Andrés Bústamante S.","doi":"10.25100/CM.V47I2.2207","DOIUrl":"https://doi.org/10.25100/CM.V47I2.2207","url":null,"abstract":"In Colombia, diabetes mellitus is a public health program for those \u0000responsible for creating and implementing strategies for prevention, \u0000diagnosis, treatment, and follow-up that are applicable at all care \u0000levels, with the objective of establishing early and sustained control \u0000of diabetes. A clinical practice guide has been developed following \u0000the broad outline of the methodological guide from the Ministry \u0000of Health and Social Welfare, with the aim of systematically \u0000gathering scientific evidence and formulating recommendations \u0000using the GRADE (Grading of Recommendations Assessment, \u0000Development and Evaluation) methodology. The current document \u0000presents in summary form the results of this process, including the \u0000recommendations and the considerations taken into account in \u0000formulating them. \u0000In general terms, what is proposed here is a screening process using the \u0000Finnish Diabetes Risk Score questionnaire adapted to the Colombian \u0000population, which enables early diagnosis of the illness, and an \u0000algorithm for determining initial treatment that can be generalized to \u0000most patients with diabetes mellitus type 2 and that is simple to apply \u0000in a primary care context. In addition, several recommendations \u0000have been made to scale up pharmacological treatment in those \u0000patients that do not achieve the objectives or fail to maintain them \u0000during initial treatment. These recommendations also take into \u0000account the evolution of weight and the individualization of glycemic \u0000control goals for special populations. Finally, recommendations have \u0000been made for opportune detection of micro- and macrovascular \u0000complications of diabetes.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"37 1","pages":"109-130"},"PeriodicalIF":1.1,"publicationDate":"2016-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73671818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Evaluación de la diásquisis transcallosa en un modelo murino de isquemia cerebral focal 局灶性脑缺血小鼠模型经胼胝体透析的评价
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-06-13 DOI: 10.25100/CM.V47I2.2146
C. Arango-Dávila, B. Muñoz, D. M. Castaño, Laura Potes, John Umbarila
{"title":"Evaluación de la diásquisis transcallosa en un modelo murino de isquemia cerebral focal","authors":"C. Arango-Dávila, B. Muñoz, D. M. Castaño, Laura Potes, John Umbarila","doi":"10.25100/CM.V47I2.2146","DOIUrl":"https://doi.org/10.25100/CM.V47I2.2146","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"32 1","pages":"87-93"},"PeriodicalIF":1.1,"publicationDate":"2016-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82669901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Frecuencia de linfocitosis monoclonal de células B en familiares de pacientes con leucemia linfoide crónica
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-06-08 DOI: 10.25100/CM.V47I2.1879
Rossana Villegas Gracia, Catalina Franco Alzate, Javier Rendón Henao, José Domingo Torres Hernández, P. Arbelaez
{"title":"Frecuencia de linfocitosis monoclonal de células B en familiares de pacientes con leucemia linfoide crónica","authors":"Rossana Villegas Gracia, Catalina Franco Alzate, Javier Rendón Henao, José Domingo Torres Hernández, P. Arbelaez","doi":"10.25100/CM.V47I2.1879","DOIUrl":"https://doi.org/10.25100/CM.V47I2.1879","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"11 1","pages":"81-86"},"PeriodicalIF":1.1,"publicationDate":"2016-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78809709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evocación al Dr. Carlos J. Finlay Barrés en el centenario de su fallecimiento 卡洛斯·j·芬利博士逝世一百周年纪念barres
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-02-19 DOI: 10.25100/CM.V47I1.2019
V. Moreno
{"title":"Evocación al Dr. Carlos J. Finlay Barrés en el centenario de su fallecimiento","authors":"V. Moreno","doi":"10.25100/CM.V47I1.2019","DOIUrl":"https://doi.org/10.25100/CM.V47I1.2019","url":null,"abstract":"About the editorial of the Professor Guillermo Llanos: \"Carlos J. Finlay: the forgotten Pasteur of America\", a hundred years after his death and through a documental review, a summary of the life and work of this great man of science was conducted. Finlay was a notable figure of the American medicine, he conceived a new infection way able to explain the propagation of the yellow fever, and added the possibility of their scientific confirmation by an experimental method. For all the above-mentioned Finlay was recognized as the humanity's benefactor Article history:","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"1 1","pages":"63-66"},"PeriodicalIF":1.1,"publicationDate":"2016-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84350195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Las visitas de equipos de cuidados paliativos: Estudio cualitativo mediante observación participante 姑息治疗团队访问:参与观察的定性研究
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-02-19 DOI: 10.25100/CM.V47I1.2022
María del Mar Alfaya Góngora, Mª José Bueno Pernias, C. H. Montoro, P. G. Mancilla, R. Juárez, M. P. G. Caro
{"title":"Las visitas de equipos de cuidados paliativos: Estudio cualitativo mediante observación participante","authors":"María del Mar Alfaya Góngora, Mª José Bueno Pernias, C. H. Montoro, P. G. Mancilla, R. Juárez, M. P. G. Caro","doi":"10.25100/CM.V47I1.2022","DOIUrl":"https://doi.org/10.25100/CM.V47I1.2022","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"2016 1","pages":"38-44"},"PeriodicalIF":1.1,"publicationDate":"2016-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73403128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Self-reported vaccination in the elderly: SABE study Bogotá, Colombia 老年人自我报告的疫苗接种:哥伦比亚波哥大<e:1>的SABE研究
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-02-19 DOI: 10.25100/CM.V47I1.2107
C. Cano, C. Reyes-Ortiz, Miguel Germán Borda, Antonio J. Arciniegas
{"title":"Self-reported vaccination in the elderly: SABE study Bogotá, Colombia","authors":"C. Cano, C. Reyes-Ortiz, Miguel Germán Borda, Antonio J. Arciniegas","doi":"10.25100/CM.V47I1.2107","DOIUrl":"https://doi.org/10.25100/CM.V47I1.2107","url":null,"abstract":"Objetivos: determinar la frecuencia de vacunacion en la poblacion adulta mayor de la ciudad de Bogota, y estimar la asociacion con factores sociodemograficos y de salud.Metodos: Este es un analisis secundario de datos del estudio SABE-Bogota, un estudio poblacional transversal que incluyo un total de 2,000 personas mayores de 60 anos. Se obtuvieron porcentajes ponderados del auto-reporte de vacunacion (influenza, neumococo, tetano). La asociacion entre la vacunacion y otras variables se evaluo mediante modelos de regresion logistica.Resultados: el 73.0% se vacuno contra la Influenza, 57.8% contra el Neumococo y el 47.6% recibio la antitetanica. Los factores que estaba independientemente asociados con la vacunacion incluyen: 1-edad (65-74 tenian probabilidad aumentada comparada con 60-64 anos); 2- nivel socioeconomico (NSE) (mayor NSE tenian menos probabilidades de tener vacunas contra la influenza y neumococo, en comparacion con aquellos con menor SES); 3- seguro de salud (con seguro contributivo o subsidiado tenian probabilidades mas altas, (entre 3 y 5 veces mayor) de tener vacunacion contra la influenza, neumococo y tetanos, en comparacion con aquellos que no tienen seguro); 4- aquellos con estado funcional mejor (puntaje mayor Lawton) tenian probabilidades mayores para todas las vacunas; 5- aquellos con morbilidad aumentada tenian probabilidades mayores para tener vacunas de influenza y neumococo.Conclusion: Las campanas de vacunacion se deben fortalecer para incrementan la cobertura, especialmente en el grupo mas reacio a la vacunacion o vulnerable para alcanzarla tales como los adultos mayores con discapacidad.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"121 1","pages":"25-30"},"PeriodicalIF":1.1,"publicationDate":"2016-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79596076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Tratamiento de la enfermedad linfoproliferativa post-trasplante renal con Rituximab y conversión a inhibidor m-TOR. 用利妥昔单抗治疗肾移植后淋巴增生性疾病并转化为m-TOR抑制剂。
IF 1.1 4区 医学
Colombia Medica Pub Date : 2016-01-01 DOI: 10.25100/cm.v47i4.1989
J. F. Nieto-Ríos, SM Gómez de los Ríos, L. M. Serna-Higuita, Catalina Ocampo-Kohn, Arbey Aristizábal-Alzate, K. Gálvez-Cárdenas, G. Zuluaga-Valencia
{"title":"Tratamiento de la enfermedad linfoproliferativa post-trasplante renal con Rituximab y conversión a inhibidor m-TOR.","authors":"J. F. Nieto-Ríos, SM Gómez de los Ríos, L. M. Serna-Higuita, Catalina Ocampo-Kohn, Arbey Aristizábal-Alzate, K. Gálvez-Cárdenas, G. Zuluaga-Valencia","doi":"10.25100/cm.v47i4.1989","DOIUrl":"https://doi.org/10.25100/cm.v47i4.1989","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"1 1","pages":"196-202"},"PeriodicalIF":1.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88312928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信